Advances in therapy

ISSNs: 0741-238X

Additional searchable ISSN (electronic): 1865-8652

Adis, United Kingdom

Scopus rating (2024): CiteScore 7.2 SJR 1.236 SNIP 1.38

Journal

Titles	Advances in therapy(2000 → …) Advances in therapy : the international journal of drug, device & diagnostic research(1984 → 2014)
Additional searchable titles	Adv Ther
ISSNs	0741-238X
Additional searchable ISSN (electronic)	1865-8652
Publisher	Adis
Country/Territory	United Kingdom
ZDB-ID	2421646-X
ZDB-ID	632651-1

Keywords

ASJC Scopus subject areas

Pharmacology (medical)

Library keywords

610 Medicine and health

Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

Paller, A. S., Pinter, A., Wine Lee, L., Aschoff, R., Zdybski, J., Schnopp, C. & Praestgaard, A. & 4 others, Bansal, A., Shumel, B., Prescilla, R. & Bastian, M., Jun 2024, Advances in therapy, 41, 6, p. 2536-2539 4 p.

Research output: Contribution to specialist publication › Corrections (errata and retractions) › peer-review

Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial

Rejnmark, L., Gosmanova, E. O., Khan, A. A., Makita, N., Imanishi, Y., Takeuchi, Y. & Sprague, S. & 14 others, Shoback, D. M., Kohlmeier, L., Rubin, M. R., Palermo, A., Schwarz, P., Gagnon, C., Tsourdi, E., Zhao, C., Makara, M. A., Ominsky, M. S., Lai, B., Ukena, J., Sibley, C. T. & Shu, A. D., Jun 2024, In: Advances in therapy. 41, 6, p. 2500-2518 19 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

Paller, A. S., Pinter, A., Wine Lee, L., Aschoff, R., Zdybski, J., Schnopp, C. & Praestgaard, A. & 4 others, Bansal, A., Shumel, B., Prescilla, R. & Bastian, M., Mar 2024, In: Advances in therapy. 41, 3, p. 1046-1061 16 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases

Fasshauer, M., Borte, M., Bitzenhofer, M., Pausch, C., Pittrow, D., Park, M. & Gladiator, A. & 1 others, Jandus, P., Dec 2023, In: Advances in therapy. 40, 12, p. 5168-5187 20 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECT

Rieckmann, P., Ziemssen, T., Penner, I.-K., Raji, A., Wagner, T., Richter, J. & Zettl, U. K., Jun 2022, In: Advances in therapy. 39, 6, p. 2749-2760 12 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (6)

Research Portal of the TU Dresden

Advances in therapy

Keywords

ASJC Scopus subject areas

Library keywords

Related content

Correction to: Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial

Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis

Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases

Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart® Injector: Results of the Prospective Cohort Study REBIFLECT